Gilead Sciences, Inc. (BIT:1GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	129,698	111,192	91,322	100,753	80,087	59,702
Market Cap Growth	18.92%	21.76%	-9.36%	25.80%	34.14%	-18.50%
Enterprise Value	141,930	127,099	105,598	117,295	97,655	61,567
Last Close Price	105.12	86.52	68.53	71.70	55.87	38.23
PE Ratio	18.76	239.83	17.82	23.45	14.63	593.74
PS Ratio	5.23	4.00	3.72	3.95	3.34	2.96
PB Ratio	7.09	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	16.61	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	15.74	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	5.73	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	11.65	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.66	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	18.18	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Capital (ROIC)	16.14%	14.07%	12.15%	14.38%	15.11%	13.94%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	5.33%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	6.02%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	2.62%	3.44%	3.96%	3.81%	4.47%	5.82%
Payout Ratio	49.10%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	1.60%	3.68%	4.28%	3.89%	4.55%	6.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.